RZLT
Rezolute Inc
NASDAQ: RZLT · HEALTHCARE · BIOTECHNOLOGY
$3.20
+2.56% today
Updated 2026-04-30
Market cap
$293.79M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.93
Dividend yield
—
52W range
$1 – $11
Volume
2.4M
Rezolute Inc (RZLT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $5132.00 | $1.10M | $7.40M | $11.26M | $10.90M | $10.63M | $2.50M | $12.25M | $10.96M | $42.61M | $152.42M | $123.72M | $132.74M | $175.49M |
| Cash & equivalents | $5132.00 | $527.00 | $5.93M | $5.28M | $4.06M | $4.49M | $1.65M | $11.57M | $9.96M | $41.05M | $150.41M | $16.04M | $70.40M | $94.11M |
| Current assets | $5132.00 | $815549.00 | $6.31M | $6.12M | $4.49M | $4.93M | $2.01M | $12.14M | $10.52M | $41.99M | $152.10M | $104.91M | $128.65M | $171.15M |
| Total liabilities | $10546.00 | $5.27M | $997921.00 | $2.21M | $2.13M | $2.10M | $6.46M | $10.50M | $3.60M | $16.51M | $2.95M | $7.55M | $11.73M | $13.36M |
| Current liabilities | $10546.00 | $5.27M | $964040.00 | $1.71M | $1.73M | $1.77M | $6.25M | $8.38M | $3.23M | $1.97M | $2.46M | $5.20M | $9.61M | $11.91M |
| Long-term debt | — | — | — | $23000.00 | — | — | — | — | — | $13.97M | $407000.00 | — | — | — |
| Shareholder equity | $-5414.00 | $-4.16M | $6.41M | $9.05M | $8.77M | $8.53M | $-3.96M | $1.75M | $7.37M | $26.10M | $149.47M | $116.17M | $121.00M | $162.13M |
| Retained earnings | $-91214.00 | $-8.02M | $-17.75M | $-29.11M | $-44.04M | $-64.32M | $-94.18M | $-126.90M | $-147.24M | $-168.14M | $-209.20M | $-260.99M | $-329.44M | $-403.86M |
| Accounts receivable | — | $350516.00 | — | $450167.00 | — | — | — | — | — | — | — | — | — | $700000.00 |
| Inventory | — | $223000.00 | $289600.00 | $67218.00 | — | — | — | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — | — | — | — | — | — | — |